[go: up one dir, main page]

PE20011313A1 - Activadores de glucoquinasa que contienen hidantoina - Google Patents

Activadores de glucoquinasa que contienen hidantoina

Info

Publication number
PE20011313A1
PE20011313A1 PE2001000389A PE2001000389A PE20011313A1 PE 20011313 A1 PE20011313 A1 PE 20011313A1 PE 2001000389 A PE2001000389 A PE 2001000389A PE 2001000389 A PE2001000389 A PE 2001000389A PE 20011313 A1 PE20011313 A1 PE 20011313A1
Authority
PE
Peru
Prior art keywords
cycloalkyl
amino
alkyl
dioxoimidazolidin
thiazol
Prior art date
Application number
PE2001000389A
Other languages
English (en)
Inventor
Kang Le
Goodnow
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20011313A1 publication Critical patent/PE20011313A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS QUE CONTIENEN HIDANTOINA DE FORMULA I DONDE R1 ES UN ANILLO HETEROCICLO AROMATICO DE 5-6 MIEMBROS CON 1-3 HETEROATOMOS OPCIONALMENTE SUSTITUTIDO CON HALO, AMINO, HIDROXILAMINO, NITRO, CIANO, ENTRE OTROS; R2 ES CICLOALQUILO C5-C7, R3 ES H, ALQUILO, CICLOALQUILO C5-C7, ARILO, HETEROCICLO AROMATICO, ENTRE OTROS; R4 ES H, ALQUILO O R3 Y R4 JUNTO A C FORMAN CICLOALQUILO C5-C7; R5 ES CO, ALQUILO; R6 ES ALQUILO; n ES 0-1. SON COMPUESTOS PREFERIDOS ESTER METILICO DEL ACIDO (S,S)-2-[[2-[4-(CICLOHEXIL)-METIL-2,5-DIOXOIMIDAZOLIDIN-1-IL)-3-CICLOPENTILPROPANOIL]AMINO]TIAZOL-4-CARBOXILICO; ESTER METILICO DEL ACIDO (S,S)-2-[[3-CICLOPENTILI-2-[4-(CICLOPENTIL)METIL-2,5-DIOXOIMIDAZOLIDIN-1-IL]PROPANOIL]AMINO]TIAZOL-4-CARBOXILICO, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO ES ACTIVADOR DE GLUCOQUINASA AL AUMENTAR LA SECRECION DE INSULINA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE LA DIABETES TIPO II
PE2001000389A 2000-05-03 2001-04-30 Activadores de glucoquinasa que contienen hidantoina PE20011313A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20149800P 2000-05-03 2000-05-03

Publications (1)

Publication Number Publication Date
PE20011313A1 true PE20011313A1 (es) 2001-12-28

Family

ID=22746054

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000389A PE20011313A1 (es) 2000-05-03 2001-04-30 Activadores de glucoquinasa que contienen hidantoina

Country Status (20)

Country Link
US (2) US6583288B2 (es)
EP (1) EP1280801B1 (es)
JP (1) JP3842131B2 (es)
KR (1) KR100505312B1 (es)
CN (1) CN1209361C (es)
AR (1) AR034253A1 (es)
AT (1) ATE304011T1 (es)
AU (2) AU2001252270B2 (es)
BR (1) BR0110492A (es)
CA (1) CA2407428C (es)
DE (1) DE60113247T2 (es)
DK (1) DK1280801T3 (es)
EC (1) ECSP014055A (es)
ES (1) ES2248309T3 (es)
MX (1) MXPA02010746A (es)
PE (1) PE20011313A1 (es)
PT (1) PT1280801E (es)
UY (1) UY26689A1 (es)
WO (1) WO2001083478A2 (es)
ZA (1) ZA200208370B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001252270B2 (en) * 2000-05-03 2005-12-15 F. Hoffmann-La Roche Ag Hydantoin-containing glucokinase activators
US6482951B2 (en) * 2000-12-13 2002-11-19 Hoffmann-La Roche Inc. Isoindolin-1-one glucokinase activators
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
US20030171411A1 (en) 2001-12-21 2003-09-11 Kodra Janos Tibor Amide derivatives as therapeutic agents
WO2004002481A1 (en) 2002-06-27 2004-01-08 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
RU2340605C2 (ru) 2002-06-27 2008-12-10 Ново Нордиск А/С Арилкарбонильные производные в качестве терапевтических средств
NZ539013A (en) 2002-10-03 2007-05-31 Novartis Ag Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
WO2004072066A1 (en) * 2003-02-11 2004-08-26 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
PL378117A1 (pl) 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
RU2386622C9 (ru) 2004-01-06 2021-04-21 Ново Нордиск А/С Гетероароматические производные мочевины и их применение в качестве активаторов глюкокиназы
CN1910166B (zh) * 2004-01-06 2012-01-04 诺和诺德公司 杂芳基脲及其作为葡糖激酶活化剂的用途
CA2561157A1 (en) 2004-04-02 2005-10-13 Novartis Ag Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
RU2412192C2 (ru) 2004-04-02 2011-02-20 Новартис Аг Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2
ES2313389T3 (es) * 2004-08-17 2009-03-01 F. Hoffmann-La Roche Ag Hidantoinas sustituidas.
CA2579717A1 (en) 2004-09-09 2006-03-23 Merck & Co., Inc. Tricyclic anilide spirolactam cgrp receptor antagonists
US7390798B2 (en) * 2004-09-13 2008-06-24 Merck & Co., Inc. Carboxamide spirolactam CGRP receptor antagonists
DE602005020656D1 (de) 2004-09-13 2010-05-27 Merck Sharp & Dohme Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptors
TW200621766A (en) * 2004-09-17 2006-07-01 Hoffmann La Roche Substituted hydantoins
WO2007006760A1 (en) 2005-07-08 2007-01-18 Novo Nordisk A/S Dicycloalkyl urea glucokinase activators
JP4651714B2 (ja) 2005-07-09 2011-03-16 アストラゼネカ アクチボラグ 糖尿病の治療においてｇｌｋ活性化剤として使用するためのヘテロアリールベンズアミド誘導体
US8106090B2 (en) 2005-07-20 2012-01-31 Eli Lilly And Company 1-amino linked compounds
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
WO2007039177A2 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
EP1951658B1 (en) 2005-11-17 2012-09-26 Eli Lilly & Company Glucagon receptor antagonists, preparation and therapeutic uses
JP2009515997A (ja) * 2005-11-18 2009-04-16 タケダ サン ディエゴ インコーポレイテッド グルコキナーゼ活性剤
FR2894962B1 (fr) * 2005-12-20 2008-03-14 Pharmamens Sarl Hydantoines a action insulinotropique
US7612212B2 (en) * 2006-02-22 2009-11-03 Hoffmann-La Roche Inc. Substituted hydantoins
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2049518B1 (en) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents.
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
TW200831081A (en) 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
EP2116533B1 (en) * 2007-03-07 2013-07-10 Kyorin Pharmaceutical Co., Ltd. Glucokinase activator
JP2010521457A (ja) * 2007-03-12 2010-06-24 メルク・シャープ・エンド・ドーム・コーポレイション 単環式アニリドスピロラクタムｃｇｒｐ受容体アンタゴニスト
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators
CN101778839A (zh) 2007-08-16 2010-07-14 霍夫曼-拉罗奇有限公司 取代的乙内酰脲
WO2009080523A1 (en) 2007-12-20 2009-07-02 F. Hoffmann-La Roche Ag Substituted hydantoins as mek kinase inhibitors
US8258134B2 (en) * 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
NZ588462A (en) 2008-04-28 2012-07-27 Kyorin Seiyaku Kk Cyclopentylacrylic acid amide derivative
PE20141375A1 (es) 2008-05-16 2014-10-23 Takeda San Diego Inc Activadores de glucoquinasa
WO2010150280A1 (en) 2009-06-22 2010-12-29 Cadila Healthcare Limited Disubstituted benzamide derivatives as glucokinase (gk) activators
JP2013500961A (ja) 2009-07-31 2013-01-10 カディラ ヘルスケア リミテッド グルコキナーゼ（ｇｋ）アクチベーターとしての置換ベンズアミド誘導体
CN105176930B (zh) 2010-03-31 2021-05-04 斯克里普斯研究所 重编程细胞
ES2671881B1 (es) * 2016-11-11 2019-03-25 Consejo Superior Investigacion Procedimiento de obtencion de polimeros con grupos isocianato
CN112040945A (zh) 2018-06-12 2020-12-04 Vtv治疗有限责任公司 葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof
AU2021289309A1 (en) 2020-06-08 2023-01-19 Vtv Therapeutics Llc Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
AU2001252270B2 (en) * 2000-05-03 2005-12-15 F. Hoffmann-La Roche Ag Hydantoin-containing glucokinase activators

Also Published As

Publication number Publication date
EP1280801B1 (en) 2005-09-07
PT1280801E (pt) 2005-11-30
ES2248309T3 (es) 2006-03-16
DK1280801T3 (da) 2006-01-23
US20010056191A1 (en) 2001-12-27
CA2407428A1 (en) 2001-11-08
MXPA02010746A (es) 2003-03-10
ECSP014055A (es) 2002-01-25
CA2407428C (en) 2010-02-02
CN1427838A (zh) 2003-07-02
ZA200208370B (en) 2004-01-26
WO2001083478A2 (en) 2001-11-08
AR034253A1 (es) 2004-02-18
JP2003531905A (ja) 2003-10-28
CN1209361C (zh) 2005-07-06
EP1280801A2 (en) 2003-02-05
JP3842131B2 (ja) 2006-11-08
DE60113247D1 (de) 2005-10-13
AU2001252270B2 (en) 2005-12-15
ATE304011T1 (de) 2005-09-15
AU5227001A (en) 2001-11-12
KR100505312B1 (ko) 2005-08-04
US6583288B2 (en) 2003-06-24
US6784298B2 (en) 2004-08-31
UY26689A1 (es) 2001-11-30
BR0110492A (pt) 2003-04-08
US20030225286A1 (en) 2003-12-04
KR20020093120A (ko) 2002-12-12
DE60113247T2 (de) 2006-06-22
WO2001083478A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
PE20011313A1 (es) Activadores de glucoquinasa que contienen hidantoina
PE20020753A1 (es) Heteroaromaticos fusionados como activadores de la glucoquinasa
AR011502A1 (es) Un compuesto substituido de acido 4-hidroxi-fenilalcanoico con actividad agonista a ppar-gamma, un metodo para prepararlo una composicion farmaceutica que lo contiene y uso del compuesto para la fabricacion de un medicamento
AR033349A1 (es) Compuesto heterociclico y composicion farmaceutica, agente hipoglucemico, agente hipolipidemico, mejorador de la resistencia a la insulina, agente terapeutico para las complicaciones de origen diabetico y agente terapeutico para la diabetes que los comprenden
PE20001584A1 (es) Activadores de la glucoquinasa
PE20020335A1 (es) Acetamida de benceno de alfa-acil- y alfa-heteroatomo-sustituido como activadores de la glucoquinasa
PE20020386A1 (es) Derivados de tetrazolil-fenil acetamida como activadores de glucoquinasa
PE20030704A1 (es) Derivados de pirrolidina
PE20040844A1 (es) Acidos fenilaceticos y derivados como inhibidores de la cox-2
BR9713136A (pt) Composto, composição inseticida, acaricida, ou nematicida, e, processos para combate e controle de pestes de inseto, acarino ou nematóide em um local e para preparação de um composto.
ES2054309T3 (es) Compuestos de urea sustituida y su preparacion y uso.
PE20040898A1 (es) Nuevos compuestos derivados de pirimidina
PE20030326A1 (es) Derivados del acido indan acetico y su uso como agentes farmaceuticos, intermediarios y metodo de preparacion
BRPI0213243B8 (pt) composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
AR038717A1 (es) Ciclopropil-azol-carboxamidas
ATE368653T1 (de) Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten
PE20031010A1 (es) Derivados de tiazol y oxazol que modulan la actividad de ppar
FI942635A0 (fi) Piperatsiinijohdannaiset 5HT1A-antagonisteina
AR041467A1 (es) Indol-3-carboxamidas como activadores de glucoquinasa (gk)
PE20091309A1 (es) Derivados de ciclohexilo como inhibidores de acetil coenzima a carboxilasa
PE20020064A1 (es) Derivados nitrilo beta-aminoacidos como inhibidores de cistein proteasas
BR8202861A (pt) Composto composicao farmaceutica processo para baixar a pressao sanguinea de seres humanos processo para preparar um composto e process para preparar uma composicao farmaceutica
DK157848C (da) Analogifremgangsmaade til fremstilling af 2-(3-hydroxy-2-oxo-1-pyrrolidinyl)carboxylsyreamidderivater samt et udgangsmateriale til anvendelse ved denne fremgangsmaade
DK536581A (da) Fremgangsmaade til fremstilling af carbonsyreamider
PE20050160A1 (es) 3-aminopirrolidinas como inhibidores de la captacion de monoaminas

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed